|
|
Volumn 368, Issue 19, 2013, Pages 1844-1845
|
|
The authors reply
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
CINACALCET;
PARATHYROID HORMONE;
VITAMIN D;
NAPHTHALENE DERIVATIVE;
ADYNAMIC BONE DISEASE;
AGE DISTRIBUTION;
ALKALINE PHOSPHATASE BLOOD LEVEL;
BONE DISEASE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
HEMODIALYSIS;
HUMAN;
KIDNEY TRANSPLANTATION;
LETTER;
NEOPLASM;
PARATHYROID HORMONE BLOOD LEVEL;
PARATHYROIDECTOMY;
PRIORITY JOURNAL;
RISK REDUCTION;
SECONDARY HYPERPARATHYROIDISM;
CHRONIC KIDNEY FAILURE;
FEMALE;
MALE;
NOTE;
RENAL REPLACEMENT THERAPY;
CARDIOVASCULAR DISEASES;
FEMALE;
HUMANS;
HYPERPARATHYROIDISM, SECONDARY;
KIDNEY FAILURE, CHRONIC;
MALE;
NAPHTHALENES;
RENAL DIALYSIS;
|
|
EID: 84877630426
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1301247 Document Type: Letter |
|
Times cited : (4)
|
|
References (1)
|
